Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: prospective clinical study-Reference-Cited by-同舟云学术

Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: prospective clinical study

Published:2023-05-30 Issue:10 Volume:110 Page:1264-1266
ISSN:0007-1323
Container-title:British Journal of Surgery
language:en
Short-container-title:

Author:

Wu Si-Yu¹²^ORCID,Li Jian-Wei¹²,Zhang Ying¹²^ORCID,Wu Huai-Liang¹²,Mo Miao²³,Hu Na²⁴,Shao Zhi-Ming¹²,Liu Guang-Yu¹²^ORCID

Affiliation:

1. Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Centre , Shanghai , China

2. Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China

3. Department of Cancer Prevention, Fudan University Shanghai Cancer Centre , Shanghai , China

4. Department of Ultrasound, Fudan University Shanghai Cancer Centre , Shanghai , China

Funder

Shanghai Sailing Programme

Publisher

Oxford University Press (OUP)

Subject

Surgery

Link

https://academic.oup.com/bjs/article-pdf/110/10/1264/51359982/znad106.pdf

Reference17 articles.

1. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis;Samiei;JAMA Surg,2021

2. Axillary nodal management following neoadjuvant chemotherapy: a review;Pilewskie;JAMA Oncol,2017

3. The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population;Zhang;Surgery,2020

4. Association of low nodal positivity rate among patients with ERBB2-positive or triple-negative breast cancer and breast pathologic complete response to neoadjuvant chemotherapy;Barron;JAMA Surg,2018

5. Correlation between pathologic complete response in the breast and absence of axillary lymph node metastases after neoadjuvant systemic therapy;Samiei;Ann Surg,2020